 Dominique Ramirez
Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intrinsically Disordered Proteins | 3 | 2025 | 48 | 1.190 |
Why?
| | Phase Transition | 1 | 2025 | 25 | 0.920 |
Why?
| | Models, Molecular | 1 | 2025 | 1571 | 0.640 |
Why?
| | Antineoplastic Agents, Alkylating | 1 | 2018 | 76 | 0.550 |
Why?
| | Prodrugs | 1 | 2018 | 54 | 0.540 |
Why?
| | Cyclophosphamide | 1 | 2018 | 275 | 0.540 |
Why?
| | Immunosuppressive Agents | 1 | 2018 | 824 | 0.400 |
Why?
| | Protein Domains | 2 | 2025 | 314 | 0.380 |
Why?
| | Dogs | 5 | 2024 | 516 | 0.370 |
Why?
| | Models, Biological | 1 | 2018 | 1758 | 0.340 |
Why?
| | Cat Diseases | 2 | 2018 | 37 | 0.280 |
Why?
| | Dog Diseases | 2 | 2019 | 140 | 0.250 |
Why?
| | Antineoplastic Agents | 3 | 2023 | 2218 | 0.220 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2020 | 218 | 0.200 |
Why?
| | Organelles | 1 | 2024 | 53 | 0.200 |
Why?
| | TCF Transcription Factors | 2 | 2020 | 19 | 0.190 |
Why?
| | Vinblastine | 1 | 2023 | 75 | 0.190 |
Why?
| | Microsomes, Liver | 2 | 2018 | 85 | 0.180 |
Why?
| | Colorectal Neoplasms | 2 | 2020 | 870 | 0.170 |
Why?
| | Cats | 2 | 2018 | 226 | 0.170 |
Why?
| | Neoplasms | 3 | 2024 | 2944 | 0.160 |
Why?
| | Peptides | 2 | 2023 | 991 | 0.150 |
Why?
| | Molecular Dynamics Simulation | 1 | 2022 | 267 | 0.150 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2019 | 24 | 0.150 |
Why?
| | Cytochrome P-450 Enzyme Inhibitors | 1 | 2018 | 13 | 0.140 |
Why?
| | Appetite Stimulants | 1 | 2018 | 2 | 0.140 |
Why?
| | DNA Helicases | 1 | 2020 | 138 | 0.140 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2020 | 166 | 0.140 |
Why?
| | Neutropenia | 1 | 2019 | 153 | 0.130 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2018 | 115 | 0.130 |
Why?
| | Chondrocytes | 1 | 2020 | 232 | 0.130 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2019 | 140 | 0.130 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2018 | 163 | 0.130 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 443 | 0.130 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 456 | 0.130 |
Why?
| | Cell Line, Tumor | 3 | 2020 | 3538 | 0.120 |
Why?
| | Enzyme Inhibitors | 1 | 2020 | 820 | 0.120 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 452 | 0.120 |
Why?
| | Doxorubicin | 1 | 2019 | 414 | 0.120 |
Why?
| | Cartilage, Articular | 1 | 2020 | 349 | 0.120 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 525 | 0.120 |
Why?
| | Cytokines | 1 | 2024 | 2079 | 0.120 |
Why?
| | Animals | 11 | 2024 | 38030 | 0.110 |
Why?
| | Liver Diseases | 1 | 2018 | 298 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 574 | 0.110 |
Why?
| | Nuclear Proteins | 1 | 2020 | 739 | 0.110 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 1075 | 0.110 |
Why?
| | Adenocarcinoma | 1 | 2020 | 927 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2020 | 1467 | 0.090 |
Why?
| | Mice | 5 | 2023 | 18266 | 0.090 |
Why?
| | Insulin | 1 | 2022 | 2524 | 0.080 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2020 | 194 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 2 | 2020 | 959 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2020 | 2411 | 0.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2020 | 1429 | 0.050 |
Why?
| | Transcription, Genetic | 2 | 2020 | 1429 | 0.050 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 2023 | 93 | 0.040 |
Why?
| | Mammals | 1 | 2023 | 287 | 0.040 |
Why?
| | Dimerization | 1 | 2022 | 174 | 0.040 |
Why?
| | Polysaccharides | 1 | 2022 | 88 | 0.040 |
Why?
| | Biological Transport | 1 | 2023 | 423 | 0.040 |
Why?
| | Drug Interactions | 1 | 2023 | 403 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2020 | 2783 | 0.040 |
Why?
| | Female | 5 | 2020 | 79080 | 0.040 |
Why?
| | RNA, Neoplasm | 1 | 2020 | 76 | 0.040 |
Why?
| | MCF-7 Cells | 1 | 2020 | 133 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2024 | 1136 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 35 | 0.040 |
Why?
| | BRCA1 Protein | 1 | 2020 | 83 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 42 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2019 | 185 | 0.040 |
Why?
| | Schools, Veterinary | 1 | 2019 | 3 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2020 | 334 | 0.040 |
Why?
| | Small Molecule Libraries | 1 | 2020 | 113 | 0.040 |
Why?
| | Horses | 1 | 2020 | 229 | 0.040 |
Why?
| | Humans | 6 | 2024 | 145625 | 0.040 |
Why?
| | Drug Design | 1 | 2019 | 179 | 0.030 |
Why?
| | Half-Life | 1 | 2018 | 157 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 561 | 0.030 |
Why?
| | Organoids | 1 | 2020 | 143 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2020 | 179 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 211 | 0.030 |
Why?
| | Area Under Curve | 1 | 2019 | 333 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2020 | 693 | 0.030 |
Why?
| | DNA Damage | 1 | 2020 | 437 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 494 | 0.030 |
Why?
| | Male | 3 | 2019 | 73014 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 928 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2020 | 1361 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2018 | 1041 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2024 | 1790 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 588 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 446 | 0.030 |
Why?
| | Linear Models | 1 | 2019 | 847 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2024 | 2007 | 0.030 |
Why?
| | Protein Binding | 1 | 2020 | 2239 | 0.020 |
Why?
| | Apoptosis | 1 | 2020 | 2436 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3633 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3396 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2020 | 1935 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4588 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 5234 | 0.010 |
Why?
|
|
Ramirez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|